statements

Trident Texofab Ltd.

BSE: 540726

Sector: Textiles

Industry Group: Textiles & Apparels

Industry: Other Textile Products

17.70-0.3 (-1.78%)

22 Oct, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Trident Texofab Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	34.49	60.46	62.56	65.98	75.95	85.46	86.90	90.96	49.93	84.29	96.36	99.48	122.06	118.02	116.09
Cost of Operating Revenue	32.07	57.72	59.51	62.95	72.51	81.73	79.81	79.78	43.08	73.72	82.03	85.48	107.47	106.85	106.68
Gross Profit	2.43	2.74	3.05	3.03	3.44	3.73	7.08	11.18	6.84	10.57	14.32	14.00	14.59	11.17	9.41
Gross Margin	7.0	4.5	4.9	4.6	4.5	4.4	8.2	12.3	13.7	12.5	14.9	14.1	11.9	9.5	8.1
Total Operating Expenses	33.55	59.34	61.57	65.13	74.91	84.14	84.80	87.14	48.07	80.97	91.69	94.98	118.23	114.53	113.20
Operating Profit	0.94	1.12	0.99	0.85	1.04	1.33	2.09	3.82	1.86	3.32	4.66	4.51	3.82	3.50	2.89
Operating Margin	2.7	1.9	1.6	1.3	1.4	1.6	2.4	4.2	3.7	3.9	4.8	4.5	3.1	3.0	2.5
Financing Income/(Expense) - Net	-0.69	-0.88	-0.80	-0.60	-0.68	-0.77	-0.72	-2.71	-2.85	-2.83	-3.71	-4.04	-4.55	-2.93	-2.75
Profit before Taxes	0.25	0.29	0.25	0.09	0.56	1.04	1.69	1.53	0.90	1.27	2.73	1.17	2.58	1.28	0.60
Income Taxes	0.13	0.06	0.07	0.03	0.23	0.29	0.42	0.63	0.55	0.29	0.51	0.09	0.07	0.58	0.39
Profit after Tax	0.12	0.22	0.18	0.06	0.33	0.75	1.27	0.90	0.35	0.98	2.22	1.08	2.51	0.70	0.21
PAT Margin	0.4	0.4	0.3	0.1	0.4	0.9	1.5	1.0	0.7	1.2	2.3	1.1	2.1	0.6	0.2
EPS - Basic - ex Extraordinary Items	0.13	0.23	0.19	0.06	0.34	0.97	1.33	0.94	0.35	0.98	2.20	1.07	2.38	0.54	-0.95
EPS - Diluted - ex Extraordinary Items	0.13	0.23	0.19	0.06	0.34	0.97	1.33	0.94	0.35	0.98	2.20	1.07	2.09	0.54	-1.00
EBIT	0.94	1.12	0.99	0.85	1.04	1.33	2.09	3.82	1.86	3.32	4.66	4.51	3.82	3.50	2.89
EBITDA	1.02	1.23	1.18	0.99	1.17	1.45	2.40	5.03	3.07	4.96	6.31	6.16	5.47	5.11	4.47
EBITDA Margin	3.0	2.0	1.9	1.5	1.5	1.7	2.8	5.5	6.1	5.9	6.5	6.2	4.5	4.3	3.9

Balance Sheet

Abridged

Understanding Balance Sheet

Trident Texofab Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	R 2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	R 2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	PR	PR	PR	PR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	16.64	23.95	26.66	36.20	22.21	40.23	36.08	39.94	40.00	40.03	46.69	52.10	73.74	78.41
Long-Term Investments	-	0.00	0.00	0.33	0.82	2.65	1.42	2.04	3.50	4.28	5.96	6.53	5.19	7.49
Property Plant & Equipment - Net	2.49	2.78	1.70	1.33	1.25	1.56	8.75	12.78	23.11	25.33	23.33	21.73	20.08	17.56
Total Non-Current Assets	2.52	2.85	1.76	1.78	2.27	4.70	10.96	15.74	27.78	30.96	30.62	29.79	26.83	32.75
Total Assets	19.16	26.80	28.42	37.99	24.48	44.94	47.04	55.68	67.77	70.99	77.31	81.90	100.58	111.16
Total Current Liabilities	14.93	21.49	23.79	34.00	15.49	32.48	26.79	29.25	30.25	30.25	37.23	42.28	40.75	37.20
Long Term Debt	2.00	2.84	1.14	0.51	5.18	4.17	9.25	13.59	22.16	23.16	21.45	20.62	10.27	15.94
Total Non-Current Liabilities	2.07	2.90	1.20	0.52	5.20	4.19	9.26	14.80	25.54	27.78	24.89	23.36	12.59	18.37
Total Liabilities	17.00	24.39	24.98	34.52	20.69	36.67	36.05	44.05	55.80	58.03	62.13	65.64	53.34	55.57
Total Shareholders' Equity	2.16	2.41	3.43	3.46	3.79	8.26	11.00	11.62	11.98	12.96	15.18	16.26	47.24	55.58
Total Equity	2.16	2.41	3.43	3.46	3.79	8.26	11.00	11.62	11.98	12.96	15.18	16.26	47.24	55.58
Total Liabilities & Equity	19.16	26.80	28.42	37.99	24.48	44.94	47.04	55.68	67.77	70.99	77.31	81.90	100.58	111.16

Cash Flow

Abridged

Understanding Cash Flow Statement

Trident Texofab Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	C 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	C 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	0.25	0.33	0.36	0.15	0.51	0.75	1.33	2.34	1.05	3.75	3.64	3.20	1.96	-1.97
Working Capital - Increase/(Decrease)	0.37	-0.84	-0.30	0.61	-0.38	-3.19	-4.94	-7.56	-1.63	-4.52	-1.07	-4.13	-19.82	-10.67
Net CF from Operating Activities	0.62	-0.51	0.06	0.76	0.13	-2.45	-3.62	-5.22	-0.58	-0.77	2.57	-0.93	-17.86	-12.64
Capital Expenditures - Net	2.35	0.39	-0.88	-0.24	0.05	0.44	7.60	1.63	9.92	3.80	0.22	0.03	-	3.84
Net CF from Investing Activities	-2.38	-0.44	0.90	-0.16	-0.54	-2.27	-6.61	-2.45	-10.24	-4.44	0.26	-0.70	4.33	-6.01
Dividends Paid - Cash - Total	-	-	-	-	-	-	0.08	0.41	-	-	-	-	-	-
Stock - Issuance/(Retirement) - Net	-	-	0.84	-	-	4.11	2.03	-	-	-	-	-	52.95	7.54
Debt - LT & ST - Issuance/(Retirement) - Total	2.00	0.84	-1.70	-0.63	2.11	-1.02	8.50	7.83	9.07	5.12	-2.81	1.73	-12.00	5.59
Net Cash Flow from Financing Activities	1.89	0.84	-0.85	-0.63	2.11	3.09	10.45	7.36	10.78	5.21	-2.81	1.73	40.95	15.60
Free Cash Flow to Equity	0.27	-0.07	-0.75	0.37	2.19	-3.90	-2.72	0.98	-1.43	0.56	-0.45	0.76	-29.85	-10.88
Free Operating CF net dividend	-1.74	-0.91	-	-	0.00	-2.88	-11.30	-7.34	-10.50	-4.92	2.36	-0.99	-17.86	-16.65
Free Operating CF	-1.74	-0.91	-	-	0.00	-2.88	-11.22	-6.93	-10.50	-4.92	2.36	-0.99	-17.86	-16.65

Business Segment Analysis

Trident Texofab Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Trident Texofab Ltd.

Regional Segment Analysis

Trident Texofab Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Trident Texofab Ltd.

Historical Segment Analysis

Track how Trident Texofab Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Trident Texofab Ltd.

Frequently Asked Questions

What is the revenue of Trident Texofab Ltd.?

The latest trailing twelve month revenue of Trident Texofab Ltd. is ₹ 116.09 Cr, reflecting a 1-year growth of -6.70% and a 3-year CAGR of 6.52%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Trident Texofab Ltd.?

The latest trailing twelve month net profit (PAT) of Trident Texofab Ltd. is ₹ 0.21 Cr, with a 3-year earnings CAGR of -55.66%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Trident Texofab Ltd.?

The trailing twelve month EBITDA of Trident Texofab Ltd. is approximately ₹ 2.89 Cr (based on an operating margin of 2.49%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Trident Texofab Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Trident Texofab Ltd. is 0.16. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Trident Texofab Ltd.?

The debt-to-equity ratio of Trident Texofab Ltd. stands at 0.66. The interest coverage ratio is 1.05x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Trident Texofab Ltd.?

The estimated book value per share of Trident Texofab Ltd. is 37.06 (derived from a P/B ratio of 0.48 and market price of ₹ 17.70), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Trident Texofab Ltd.?

The trailing twelve month operating cash flow of Trident Texofab Ltd. is ₹ -12.64 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Trident Texofab Ltd. report consolidated or standalone financials?

Trident Texofab Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.